Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F]MK-9470 PET

NeuroImage

Volumn 39, Issue 4, 2008, Pages 1533-1541

  Van Laere, Koen ^a   Goffin, Karolien ^a   Casteels, Cindy ^a   Dupont, Patrick ^a   Mortelmans, Luc ^a   de Hoon, Jan ^b   Bormans, Guy ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Aging; Cannabinoid type 1 receptor; Gender; PET; Statistical parametric mapping

Indexed keywords

CANNABINOID 1 RECEPTOR; MK 9470; N [2 (3 CYANOPHENYL) 3 [4 (2 FLUOROETHOXY)PHENYL] 1 METHYLPROPYL] 2 (5 METHYL 2 PYRIDYLOXY) 2 METHYLPROPONAMIDE F 18; SEX HORMONE; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; BLOOD SAMPLING; BRAIN SIZE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; ELECTROPHYSIOLOGY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIMBIC SYSTEM; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL CORTEX;

ADOLESCENT; ADULT; AGED; AGING; AREA UNDER CURVE; BRAIN; BRAIN CHEMISTRY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RADIOPHARMACEUTICALS; RECEPTOR, CANNABINOID, CB1; REFERENCE VALUES; SEX CHARACTERISTICS;

EID: 38749128371     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.10.053     Document Type: Article

References (51)

1. Barrero F.J., Ampuero I., Morales B., Vives F., de Dios Luna del Castillo, Hoenicka J., and Garcia Y.J. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmacogenomics J. 5 (2005) 135-141
2. Belue R.C., Howlett A.C., Westlake T.M., and Hutchings D.E. The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol. Teratol. 17 (1995) 25-30
3. Berrendero F., Romero J., Garcia-Gil L., Suarez I., De la C.P., Ramos J.A., and Fernandez-Ruiz J.J. Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats. Biochim. Biophys. Acta 1407 (1998) 205-214
4. Biegon A., and Kerman I.A. Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain. NeuroImage 14 (2001) 1463-1468
5. Bilkei-Gorzo A., Racz I., Valverde O., Otto M., Michel K., Sarstre M., and Zimmer A. Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 15670-15675
6. Briggs G.G., and Nebes R.D. Patterns of hand preference in a student population. Cortex 11 (1975) 230-238
7. Burns H.D., Van Laere K., Sanabria-Bohorquez S., Hamill T.G., Bormans G., Eng W.S., Gibson R., Ryan C., Connolly B., Patel S., et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 9800-9805
8. Calder A.J., Lawrence A.D., and Young A.W. Neuropsychology of fear and loathing. Nat. Rev., Neurosci. 2 (2001) 352-363
9. Coddington E., Lewis C., Rose J.D., and Moore F.L. Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior. Endocrinology 148 (2007) 493-500
10. Cohen L.S. Gender-specific considerations in the treatment of mood disorders in women across the life cycle. J. Clin. Psychiatry 64 Suppl. 15 (2003) 18-29
11. Coutts A.A., Anavi-Goffer S., Ross R.A., MacEwan D.J., Mackie K., Pertwee R.G., and Irving A.J. Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. J. Neurosci. 21 (2001) 2425-2433
12. De Jesus M.L., Salles J., Meana J.J., and Callado L.F. Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates. Neuroscience 140 (2006) 635-643
13. Di Marzo V., Bifulco M., and De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat. Rev., Drug Discov. 3 (2004) 771-784
14. Glass M., Dragunow M., and Faull R.L. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77 (1997) 299-318
15. Gonzalez S., Mena M.A., Lastres-Becker I., Serrano A., de Yebenes J.G., Ramos J.A., and Fernandez-Ruiz J. Cannabinoid CB(1) receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice. Brain Res. 1046 (2005) 195-206
16. Hansen H.H., Schmid P.C., Bittigau P., Lastres-Becker I., Berrendero F., Manzanares J., Ikonomidou C., Schmid H.H., Fernandez-Ruiz J.J., and Hansen H.S. Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J. Neurochem. 78 (2001) 1415-1427
17. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., De Costa B.R., and Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1932-1936
18. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., De Costa B.R., and Rice K.C. Characterization and localization of cannabinoid receptors in rat brain, a quantitative in vitro autoradiographic study. J. Neurosci. 11 (1991) 563-583
19. Horti A.G., Fan H., Kuwabara H., Hilton J., Ravert H.T., Holt D.P., Alexander M., Kumar A., Rahmim A., Scheffel U., et al. 11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors. J. Nucl. Med. 47 (2006) 1689-1696
20. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., et al. International Union of Pharmacology: XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54 (2002) 161-202
21. Hunt C.M., Westerkam W.R., and Stave G.M. Effect of age and gender on the activity of human hepatic CYP3A. Biochem. Pharmacol. 44 (1992) 275-283
22. Ibrahim M.M., Porreca F., Lai J., Albrecht P.J., Rice F.L., Khodorova A., Davar G., Makriyannis A., Vanderah T.W., Mata H.P., et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3093-3098
23. Iversen L. Cannabis and the brain. Brain 126 (2003) 1252-1270
24. Kawamura K., Kimura Y., Tsukada H., Kobayashi T., Nishiyama S., Kakiuchi T., Ohba H., Harada N., Matsuno K., Ishii K., et al. An increase of sigma receptors in the aged monkey brain. Neurobiol. Aging 24 (2003) 745-752
25. Koeppe R.A., Frey K.A., Snyder S.E., Meyer P., Kilbourn M.R., and Kuhl D.E. Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain. J. Cereb. Blood Flow Metab. 19 (1999) 1150-1163
26. Leterrier C., Laine J., Darmon M., Boudin H., Rossier J., and Lenkei Z. Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors. J. Neurosci. 26 (2006) 3141-3153
27. Liu P., Bilkey D.K., Darlington C.L., and Smith P.F. Cannabinoid CB1 receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and age-related changes. Brain Res. 979 (2003) 235-239
28. Maccarrone M., Attina M., Bari M., Cartoni A., Ledent C., and Finazzi-Agro A. Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages. J. Neurochem. 78 (2001) 339-348
29. Mani S.K., Mitchell A., and O'Malley B.W. Progesterone receptor and dopamine receptors are required in Delta 9-tetrahydrocannabinol modulation of sexual receptivity in female rats. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1249-1254
30. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutierrez S.O., van der S.M., et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
31. Marx J. Drug development. Drugs inspired by a drug. Science 311 (2006) 322-325
32. Mato S., and Pazos A. Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain. Neuropharmacology 46 (2004) 716-726
33. Meltzer C.C., Cantwell M.N., Greer P.J., Ben-Eliezer D., Smith G., Frank G., Kaye W.H., Houck P.R., and Price J.C. Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction. J. Nucl. Med. 41 (2000) 1842-1848
34. Muller-Gartner H.W., Links J.M., Prince J.L., Bryan R.N., McVeigh E., Leal J.P., Davatzikos C., and Frost J.J. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J. Cereb. Blood Flow Metab. 12 (1992) 571-583
35. Paradisi A., Oddi S., and Maccarrone M. The endocannabinoid system in ageing: a new target for drug development. Curr. Drug Targets 7 (2006) 1539-1552
36. Pi-Sunyer F., Aronne X., Heshmati L.J., Devin H.M., and Rosenstock J. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295 (2006) 761-775
37. Podruchny T.A., Connolly C., Bokde A., Herscovitch P., Eckelman W.C., Kiesewetter D.O., Sunderland T., Carson R.E., and Cohen R.M. In vivo muscarinic 2 receptor imaging in cognitively normal young and older volunteers. Synapse 48 (2003) 39-44
38. Quarantelli M., Berkouk K., Prinster A., Landeau B., Svarer C., Balkay L., Alfano B., Brunetti A., Baron J.C., and Salvatore M. Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J. Nucl. Med. 45 (2004) 192-201
39. Rodriguez D.F., Cebeira M., Ramos J.A., Martin M., and Fernandez-Ruiz J.J. Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sci. 54 (1994) 159-170
40. Romero J., Berrendero F., Garcia-Gil L., De la C.P., Ramos J.A., and Fernandez-Ruiz J.J. Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience 84 (1998) 1075-1083
41. Talairach J., and Tournoux P. Co-Planar Stereotactic Atlas of the Human Brain. 1 ed. (1988), Thieme Medical Publishers, Stuttgart
42. van der Stelt M., and Di Marzo V. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur. J. Pharmacol. 480 (2003) 133-150
43. van der Stelt M., Veldhuis W.B., Bar P.R., Veldink G.A., Vliegenthart J.F., and Nicolay K. Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity. J. Neurosci. 21 (2001) 6475-6479
44. Van Laere K. In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans. Eur. J. Nucl. Med. Mol. Imaging 34 (2007) 1719-1726
45. Van Laere K.J., and Dierckx R.A. Brain perfusion SPECT: age- and sex-related effects correlated with voxel-based morphometric findings in healthy adults. Radiology 221 (2001) 810-817
46. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310 (2005) 329-332
47. Vinod K.Y., and Hungund B.L. Role of the endocannabinoid system in depression and suicide. Trends Pharmacol. Sci. 27 (2006) 539-545
48. Wang L., Liu J., Harvey-White J., Zimmer A., and Kunos G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1393-1398
49. Westlake T.M., Howlett A.C., Bonner T.I., Matsuda L.A., and Herkenham M. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 63 (1994) 637-652
50. Wilson R.I., and Nicoll R.A. Endocannabinoid signaling in the brain. Science 296 (2002) 678-682
51. Yasuno, F., Brown, A.K., Zoghbi, S.S., Krushinski, J.H., Chernet, E., Tauscher, J., Schaus, J.M., Phebus, L.A., Chesterfield, A.K., Felder, C.C., et al., in press. The PET radioligand [(11)C]MePPEP binds reversibly and with high specific signal to cannabinoid CB(1) receptors in nonhuman primate brain. Neuropsychopharmacology. doi:10.1038/sj.npp.1301402.